Enter Your Email Address to Receive a
Copy of MedicExhange Member Demograhpics

Plans to establish first of its kind, one-stop "See & Treat" Oncology Centers in Tier II and III Towns

• KIMS to establish complete Oncology Centers at an investment of Rs.200 Crores
• GE Discovery PET / CT imaging systems to detect disease at earliest possible stages; GE PET-Trace Medical Cyclotrons to produce Bio-markers; Varian Linear Accelerators to provide radiotherapy treatment.
• India has an estimated 2.5 million patients undergoing treatment.

 Krishna Institute of Medical Sciences (KIMS), GE Healthcare and Varian Medical Systems are announcing a cooperative working relationship to jointly address the growing oncology needs in rural India. Under the cooperative relationship, KIMS plans to establish 10 "See and Treat" oncology centers with an investment of Rs.200 crores to acquire latest technology for these centres. The proposed network of centers will have one advanced GE Discovery PET / CT Molecular Imaging Systems each for detecting the disease at its earliest possible stage and 3 centrally located cyclotrons for producing FDG bio-markers required for the disease detection. Several of these centers will be equipped with radiotherapy and radio-surgery technology from Varian Medical Systems for treating patients. These first-of-its-kind, stand-alone, "See and Treat" cancer care centers are targeted for:

• Vijayawada &, Visakhapatanam in Andhra Pradesh
• Bhubaneshwar in Orissa,
• Thrissur in Kerala,
• Pune & Nagpur in Maharashtra;
• Raipur and Indore in Madhyapradesh;
• Coimbatore, Tamil Nadu;
• Patna, Bihar

GE Healthcare and Varian Medical Systems will provide turnkey assistance to equip these "See and Treat" cancer care centers in the above mentioned towns. The centers are expected to be functional by June 2011 and will also be capable of providing diagnostic services in cardiology and neurology.

"Cancer is a leading cause of death in India, but it can be treated and controlled if detected early. We do see a new good trend of cancer centers coming up in India - primarily in metropolitan areas. However, cancer is equally prevalent in small towns and rural areas. In fact India has among the world’s most prevalent incidence of mouth and tongue cancer. This cancer is killing people in small towns and villages because of the limited availability of specialists and medical technologies. Low awareness is another important factor and leads to non-recognition of disease even when symptoms are present. I have observed that people put off their diagnosis and sometimes treatment because it’s too expensive for them to travel to metropolitan clinics that have the needed technology and capabilities. People often come for diagnosis when the cancer is in stage III or IV when treatment is ineffective and the disease is irreversible. Our vision of locating "See and Treat" centers close to their homes will make early detection and treatment easy, cost-effective and help save many lives. I intend to start with 10 centers, but wish I could have one in every small town in India to help early detection and treatment of cancer" said Dr B Bhaskar Rao, Managing Director and Chief Executive Officer, Krishna Institute of Medical Sciences, Hyderabad.

"We are excited to begin this co-operation with GE Healthcare and Varian Medical Systems - both leading suppliers of healthcare solutions. Together, we can provide the healthcare sector in India with sophisticated and unparalleled molecular imaging diagnostic services and treatment, leveraging on the world-class facilities offered by our centers," he added.

A one-stop-facility for cancer, cardiac and neuro care in Tier II and III towns:

Molecular imaging is a combination of fields such as biology, medicine, pharmaceutics, physics, chemistry and engineering that allows physicians to detect, treat and monitor disease at the body’s cellular levels. Molecular imaging and scanning capabilities make multi-medical therapy possible. The most exciting result is the ability to diagnose health problems, such as cancer/ tumors, coronary artery disease, and neurological diseases in patients with no clear symptoms. Physicians can treat different patients according to specific situations, slow the progression of the disease, and evaluate the effects of treatment.

"Molecular imaging has huge potential to enable detection of diseases at a much earlier stage and change the way we manage the patient today,” said Terri Bresenham, Vice President, Molecular Imaging Business, GE Healthcare. “Molecular imaging techniques in combination with specific biomarkers are helping physicians to choose suitable medications for a particular patient, predict and monitor the effects of those medications, and personalize patients' treatments - hence contributing to a more efficient and higher quality treatment of common maladies like cancer, cardiovascular diseases or neurological disorders. Our vision is to detect and treat the molecular causes of diseases long before the patient ever experiences any symptom and GE is at the forefront of developing these early health solutions that will transform the future of healthcare. We are very pleased to partner with KIMS to take this advanced technology to the people in tier II and III towns, where such facilities do not exist today.”

The GE Discovery PET / CT systems will help doctors determine whether a suspicious growth is cancerous or benign in a single exam. Previously, doctors had to put patients through two separate scans to get similar information – with limited success. Medical research published in the New England Journal of Medicine indicates integrated PE T/ CT exams provide extra information beyond that obtained with visually correlated PET and CT in 41% of cases because of its proven pinpoint accuracy in locating disease.

The proposed "See & Treat" cancer care centers will feature three cyclotrons - GE PET-Trace and CGMP laboratory that produces high yields of radioisotope biomarkers. These are essential for accurate PET diagnosis.

Mr. V. Raja, President, GE Healthcare South Asia, said: “We are extremely pleased to partner with KIMS, which is one of India’s most respected institutions. This strategic partnership is in line with our vision of "healthymagination" to reduce costs, increase healthcare access and improve quality & efficiency. GE Healthcare and KIMS shares a common dream of creating healthcare access for more people at affordable costs. We are both driven by a desire to change the future of healthcare by helping patients experience our Early Health, which focuses on early diagnosis rather than late disease. Together, we will be exploring the possibility of creating such centers of excellence across India.

Radiotherapy Treatment in Small Towns:

“This ambitious vision should make a big difference in providing advanced radiotherapy treatments for cancer patients in rural areas,” says Michael Sandhu, regional head of Varian’s Oncology Systems business. “Varian has always focused on providing technology and equipment that increases access to advanced radiotherapy treatments by lowering the overall cost per treatment. For example, our UNIQUE linear accelerators enable cutting-edge conformal radiotherapy techniques such as image-guided RapidArc  intensity modulated radiotherapy to be offered on a lower-cost treatment machine. India has far fewer treatment machines than its cancer population needs, so this is a very positive step forwards. Together with KIMS and GE, we can help address this need.”

"GE Healthcare is the largest supplier of molecular imaging and Cyclotron systems globally and in India. Varian Medical Systems is the world leader in systems for treating cancer with radiotherapy and radiosurgery. GE and Varian are collaborators in marketing and developing newer oncology diagnostic and treatment solutions and together we can present a holistic approach to KIMS vision for cancer detection and treatment," added Dr Rao.